File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1155/2012/106583
- Scopus: eid_2-s2.0-84863268234
- WOS: WOS:000301356500001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral candida species and the synergy with fluconazole against azole-resistant Candida albicans
Title | Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral candida species and the synergy with fluconazole against azole-resistant Candida albicans |
---|---|
Authors | |
Issue Date | 2012 |
Publisher | Oxford University Press. The Journal's web site is located at http://ecam.oxfordjournals.org/ |
Citation | Evidence-Based Complementary And Alternative Medicine, 2012, v. 2012 How to Cite? |
Abstract | This study was designed to evaluate the in vitro antifungal activities of four traditional Chinese medicine (TCM) extracts. The inhibitory effects of pseudolaric acid B, gentiopicrin, rhein, and alion were assessed using standard disk diffusion and broth microdilution assays. They were tested against six oral Candida species, Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, Candida dubliniensis, and Candida guilliermondii, including clinical isolates from HIV-negative, HIV-positive, and Sjgren's syndrome patients. It was found that pseudolaric acid B had the most potent antifungal effect and showed similar antifungal activity to all six Candida spp, and to isolates from HIV-negative, HIV-positive, and Sjgren's syndrome patients. The MIC values ranged from 16 to 128 μg/mL. More interestingly, a synergistic effect of pseudolaric acid B in combination with fluconazole was observed. We suggest that pseudolaric acid B might be a potential therapeutic fungicidal agent in treating oral candidiasis. Copyright 2012 Zhimin Yan et al. |
Persistent Identifier | http://hdl.handle.net/10722/154706 |
ISSN | 2021 Impact Factor: 2.650 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yan, Z | en_US |
dc.contributor.author | Hua, H | en_US |
dc.contributor.author | Xu, Y | en_US |
dc.contributor.author | Samaranayake, LP | en_US |
dc.date.accessioned | 2012-08-08T08:27:01Z | - |
dc.date.available | 2012-08-08T08:27:01Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.citation | Evidence-Based Complementary And Alternative Medicine, 2012, v. 2012 | en_US |
dc.identifier.issn | 1741-427X | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/154706 | - |
dc.description.abstract | This study was designed to evaluate the in vitro antifungal activities of four traditional Chinese medicine (TCM) extracts. The inhibitory effects of pseudolaric acid B, gentiopicrin, rhein, and alion were assessed using standard disk diffusion and broth microdilution assays. They were tested against six oral Candida species, Candida albicans, Candida glabrata, Candida tropicalis, Candida krusei, Candida dubliniensis, and Candida guilliermondii, including clinical isolates from HIV-negative, HIV-positive, and Sjgren's syndrome patients. It was found that pseudolaric acid B had the most potent antifungal effect and showed similar antifungal activity to all six Candida spp, and to isolates from HIV-negative, HIV-positive, and Sjgren's syndrome patients. The MIC values ranged from 16 to 128 μg/mL. More interestingly, a synergistic effect of pseudolaric acid B in combination with fluconazole was observed. We suggest that pseudolaric acid B might be a potential therapeutic fungicidal agent in treating oral candidiasis. Copyright 2012 Zhimin Yan et al. | en_US |
dc.language | eng | en_US |
dc.publisher | Oxford University Press. The Journal's web site is located at http://ecam.oxfordjournals.org/ | en_US |
dc.relation.ispartof | Evidence-based Complementary and Alternative Medicine | en_US |
dc.title | Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral candida species and the synergy with fluconazole against azole-resistant Candida albicans | en_US |
dc.type | Article | en_US |
dc.identifier.email | Samaranayake, LP:lakshman@hku.hk | en_US |
dc.identifier.authority | Samaranayake, LP=rp00023 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1155/2012/106583 | en_US |
dc.identifier.scopus | eid_2-s2.0-84863268234 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-84858259469&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 2012 | en_US |
dc.identifier.isi | WOS:000301356500001 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Yan, Z=55094076000 | en_US |
dc.identifier.scopusauthorid | Hua, H=21734738900 | en_US |
dc.identifier.scopusauthorid | Xu, Y=55088256600 | en_US |
dc.identifier.scopusauthorid | Samaranayake, LP=7102761002 | en_US |
dc.identifier.issnl | 1741-427X | - |